Clinical Infant Nutrition: Global Markets

Report Highlights

The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.

Report Includes

• 17 data tables and 32 additional tables
• An up-to-date overview and analysis of the global market for clinical infant nutrition
• Analyses of the global market trends, with historical sales data for 2018-2021, and projections of compound annual growth rates (CAGRs) through 2026
• Highlights of the current and future market potential for clinical infant nutrition, and areas of focus to forecast this market into various segments and sub-segments
• Evaluation and forecast the clinical infant nutrition market size, projected growth trends, and corresponding market share analysis segmented by nutrition type, formulation technique, product form, and geographic region
• Assessment of major driving factors, trends, opportunities and challenges in this innovation driven market, along with technology advances and regulatory implications within the marketplace
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
• Company profiles of major players within the industry, including Abbott Laboratories, Baxter International Inc., Danone, Fresenius, Nestlé, and Reckitt Benckiser Group Plc

Report Scope

The current report will provide detailed information regarding the infant nutrition market. It analyzes the market trends of infant nutrition with data from 2020, estimates from 2021, projections of compound annual growth rates (CAGR) through 2026 (i.e., forecast period 2021 through 2026) and regional markets of infant nutrition devices. This report will highlight the current and future market potential for infant nutrition, as well as a detailed analysis of the competitive environment. It report will cover regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2026 and the market shares for key market players.

Based on infant formulas, the market is segmented into specialized infant formulas and standard infant formulas. Based on nutrition type, the market is segmented into enteral and parenteral nutrition. The market is also segmented by powdered formula, concentrated liquid formula and ready-to-use formula.

The market has been segmented into various major geographic regions, including North America, Europe, Asia-Pacific and the Rest of the World. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Japan, China, India) will be covered within the regional segment. For market estimates, data are provided using 2020 as the base year, with estimates for 2021 and forecast value for 2026.

A holistic study of the market has been carried out, incorporating various factors, including country-specific demographic conditions and business cycles, and market-specific microeconomic influences needed to analyze future market trends. Key vendor analysis, new products, developments and financials are also provided to enable easy decision making.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)